Coya Therapeutics

COYANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$112.829 M

$4.81 +5.02%

Close of 7 Aug 2026

Revenue

$7.95M

#3214 by revenue

Earnings

-$21.2M

Loss-making

Shares outstanding

23,457,183

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#301Anixa BiosciencesANIX$116.4M
#302Cue BiopharmaCUE$113.9M
#303Coya TherapeuticsCOYA$112.8M
#304Polaryx TherapeuticsPLYX$112.7M
#305RafaelRFL$106.6M

Where these numbers come from

Share counts and financials for Coya Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.